Heart rhythm watch: do ICU patients face hidden AF risk after leaving hospital?
NCT ID NCT05229211
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 100 ICU patients who developed new atrial fibrillation (AF) during their stay. Using a chest-worn heart monitor, researchers track whether AF returns after leaving the ICU and up to 3 months after hospital discharge. The goal is to understand who might need long-term monitoring or treatment to prevent strokes and heart failure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cardiac monitoring patch (VitalConnect)
What this could lead to
If successful, this study could show which ICU patients need follow-up care to prevent strokes or heart failure from returning atrial fibrillation.
What could go wrong
This is a small observational study (100 people) that only monitors, not treats. It may not prove that monitoring reduces risks or applies to all ICU patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oxford University Hospitals Trust
Oxford, Oxfordshire, OX3 9DU, United Kingdom